Search





Search





Markets
/
Stocks
/
axsm
/

Axsome Therapeutics Inc

AXSM

Add to Watchlist

217.990USD

-16.650-7.10%

Close 07-31 16:00（ET）Quotes delayed by 15 min

11.22BMarket Cap

LossP/E TTM

Axsome Therapeutics Inc

217.990

-16.650-7.10%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

AXSM Cash Flow Statement

You can access the annual and quarterly cash flow statements of Axsome Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q1

FY2014Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

52.28%-20.70M

28.81%-18.65M

105.61%1.05M

-7.68%-32.42M

18.88%-43.38M

13.70%-26.20M

65.21%-18.63M

45.60%-30.11M

-818.52%-53.47M

-10.15%-30.36M

-135.29%-53.55M

-65.04%-55.35M

82.17%-5.82M

4.43%-27.56M

15.01%-22.76M

-32.07%-33.54M

-19.98%-32.65M

-40.32%-28.84M

-70.17%-26.78M

-34.39%-25.39M

-16.94%-27.22M

-17.00%-20.55M

-48.06%-15.73M

-117.64%-18.90M

-145.00%-23.27M

-79.37%-17.57M

-79.75%-10.63M

-13.23%-8.68M

-42.19%-9.50M

-55.68%-9.79M

8.30%-5.91M

-8.04%-7.67M

-0.66%-6.68M

12.82%-6.29M

-34.25%-6.45M

-33.53%-7.10M

-68.11%-6.64M

-220.62%-7.22M

-149.80%-4.80M

---5.31M

-240.65%-3.95M

---2.25M

-52.87%-1.92M

---1.16M

---1.26M

Net income from continuing operations

-8.63%-64.54M

61.88%-28.56M

26.89%-47.23M

39.54%-47.97M

13.08%-59.41M

24.06%-74.91M

-3.86%-64.60M

-18.13%-79.34M

-509.35%-68.36M

-61.09%-98.65M

-38.77%-62.20M

-62.10%-67.17M

71.69%-11.22M

-80.24%-61.24M

-28.50%-44.82M

-28.36%-41.44M

-35.45%-39.63M

-16.50%-33.98M

-52.16%-34.88M

-76.16%-32.28M

9.93%-29.26M

-17.57%-29.16M

-19.80%-22.92M

-33.17%-18.33M

-205.29%-32.48M

-158.49%-24.81M

-131.05%-19.14M

-66.19%-13.76M

-121.42%-10.64M

-29.16%-9.60M

-28.73%-8.28M

-16.89%-8.28M

39.89%-4.81M

-1.39%-7.43M

10.58%-6.43M

-3.99%-7.08M

-36.30%-8.00M

-327.61%-7.33M

-57.22%-7.19M

---6.81M

-174.09%-5.87M

---1.71M

-1707.91%-4.58M

---2.14M

---253.12K

Operating gains losses

10.97%2.37M

9.70%2.27M

16.98%2.41M

12.69%2.25M

16.49%2.13M

19.14%2.07M

18.24%2.06M

18.00%1.99M

10.17%1.83M

2.83%1.74M

3.72%1.74M

70.01%1.69M

4436.52%1.66M

5350.55%1.69M

6071.38%1.68M

10090.21%993.44K

340.02%36.64K

320.55%31.05K

393.12%27.23K

76.48%9.75K

53.16%8.33K

36.91%7.38K

-41.19%5.52K

-50.28%5.52K

-52.48%5.44K

-55.83%5.39K

-28.20%9.39K

-5.15%11.11K

-4.18%11.44K

8.28%12.21K

21.27%13.08K

12.77%11.71K

18.05%11.94K

15.62%11.27K

91.94%10.78K

245.89%10.39K

378.84%10.11K

679.46%9.75K

400.71%5.62K

--3.00K

594.74%2.11K

--1.25K

--1.12K

--304.00

--0.00

Other non-cash items

202.98%1.00M

-9.11%958.00K

-3.75%975.00K

1073.63%11.53M

-199.49%-974.00K

33.59%1.05M

4.43%1.01M

-28.16%982.00K

9.02%979.00K

17.72%789.00K

31.62%970.00K

85.04%1.37M

80.25%898.00K

33.65%670.26K

30.75%736.94K

33.76%738.78K

-7.54%498.21K

43.46%501.52K

-59.20%563.62K

208.54%552.33K

-92.65%538.86K

96.13%349.60K

680.76%1.38M

-4.47%179.01K

6725.64%7.33M

117.23%178.25K

99.74%176.92K

94.14%187.38K

-0.97%107.43K

-30.25%82.06K

-25.95%88.58K

-17.93%96.52K

-6.19%108.48K

70.68%117.65K

--119.62K

--117.61K

--115.64K

104.10%68.93K

-100.00%0.00

--0.00

-100.00%0.00

---1.68M

266.00%2.47M

--17.87K

---1.49M

Change in working capital

265.42%16.44M

-155.41%-6.99M

77.49%8.60M

-164.84%-14.73M

-48.42%-9.94M

246.67%12.61M

155.56%4.85M

271.98%22.72M

32.64%-6.70M

-77.74%3.64M

-183.13%-8.72M

-321.77%-13.21M

-761.82%-9.94M

1371.24%16.35M

486.03%10.49M

-459.04%-3.13M

48.35%-1.15M

-148.55%-1.29M

-38.99%1.79M

117.80%872.34K

-755.89%-2.23M

-37.57%2.65M

-59.05%2.93M

-222.72%-4.90M

-11.53%-260.99K

882.32%4.24M

279.03%7.17M

12481.12%3.99M

-263.50%-234.02K

-214.24%-542.28K

455.17%1.89M

105.09%31.74K

-74.86%143.13K

56.98%-172.57K

-127.61%-532.32K

-161.62%-623.90K

-54.82%569.24K

-156.36%-401.14K

833.25%1.93M

--1.01M

80.24%1.26M

--711.80K

-160.80%-262.96K

--699.10K

--432.51K

-Change in receivables

-37.13%-26.60M

-56.14%-27.96M

161.75%2.32M

-97.96%-37.43M

-193.21%-19.40M

-9.14%-17.91M

65.89%-3.75M

16.40%-18.91M

6.75%-6.62M

5.70%-16.41M

-166.19%-11.01M

-39.89%-22.62M

---7.09M

---17.40M

---4.13M

---16.17M

----

-Change in inventory

-304.65%-4.87M

15.74%-3.49M

-422.63%-6.93M

-866.10%-4.04M

-23.87%-1.20M

-130.81%-4.14M

-23.45%2.15M

150.19%528.00K

78.01%-972.00K

60.46%-1.79M

376.99%2.81M

-479.44%-1.05M

---4.42M

---4.54M

---1.01M

--277.25K

----

-Change in prepaid expenses

-145.02%-9.87M

328.33%6.14M

-115.28%-3.45M

-247.77%-331.00K

-2.86%-4.03M

208.81%1.43M

-80.52%-1.60M

131.55%224.00K

-61.86%-3.92M

-307.55%-1.32M

26.47%-888.00K

-181.39%-710.00K

-16.52%-2.42M

-190.77%-323.15K

-3600.48%-1.21M

1541.98%872.37K

-815.19%-2.08M

-53.38%356.02K

104.45%34.50K

-135.13%-60.50K

-318.78%-226.93K

321.31%763.62K

-451.28%-774.81K

-46.15%172.19K

-7.11%103.72K

134.68%181.25K

-52.49%220.57K

577.58%319.78K

-29.06%111.67K

1.81%-522.69K

381.12%464.29K

-119.90%-66.96K

-21.85%157.41K

-3.67%-532.32K

-67.59%96.50K

289.78%336.53K

2121.88%201.44K

21.27%-513.46K

425.77%297.77K

---177.32K

-85.99%9.07K

---652.21K

-499.19%-91.41K

--64.72K

---15.26K

-Change in other current assets

----

3434.31%184.55K

---184.55K

----

--0.00

96.88%-5.54K

----

100.00%0.00

-100.00%0.00

---177.50K

105.49%3.70K

-134.17%-3.70K

480.60%29.09K

--0.00

-2634.21%-67.45K

-85.18%10.83K

107.30%5.01K

--0.00

---2.47K

1229.26%73.06K

-27.87%-68.66K

100.00%0.00

--0.00

79.04%-6.47K

-1381.27%-53.70K

92.93%-1.63K

--0.00

---30.88K

---3.63K

---23.00K

--0.00

Cash from non-recurring investing activities

Cash from operating activities

52.28%-20.70M

28.81%-18.65M

105.61%1.05M

-7.68%-32.42M

18.88%-43.38M

13.70%-26.20M

65.21%-18.63M

45.60%-30.11M

-818.52%-53.47M

-10.15%-30.36M

-135.29%-53.55M

-65.04%-55.35M

82.17%-5.82M

4.43%-27.56M

15.01%-22.76M

-32.07%-33.54M

-19.98%-32.65M

-40.32%-28.84M

-70.17%-26.78M

-34.39%-25.39M

-16.94%-27.22M

-17.00%-20.55M

-48.06%-15.73M

-117.64%-18.90M

-145.00%-23.27M

-79.37%-17.57M

-79.75%-10.63M

-13.23%-8.68M

-42.19%-9.50M

-55.68%-9.79M

8.30%-5.91M

-8.04%-7.67M

-0.66%-6.68M

12.82%-6.29M

-34.25%-6.45M

-33.53%-7.10M

-68.11%-6.64M

-220.62%-7.22M

-149.80%-4.80M

---5.31M

-240.65%-3.95M

---2.25M

-52.87%-1.92M

---1.16M

---1.26M

Investing cash flow

Net cash from continuing investing activities

-64.20%121.00K

136.67%71.00K

-35.56%58.00K

-75.00%13.00K

244.90%338.00K

328.57%30.00K

-75.74%90.00K

-60.90%52.00K

38.03%98.00K

-96.13%7.00K

461.64%371.00K

-44.92%133.00K

-66.78%71.00K

--180.86K

-74.46%66.06K

1179.12%241.46K

612.57%213.74K

-100.00%0.00

1642.52%258.68K

1221.92%18.88K

221.46%30.00K

1288.57%20.29K

364.49%14.85K

-87.54%1.43K

--9.33K

--1.46K

-62.32%3.20K

18.93%11.46K

-100.00%0.00

135.39%8.48K

183.92%9.64K

402.79%14.58K

-99.98%1.00

-95.28%3.60K

-70.74%3.40K

-72.78%2.90K

47.25%6.05K

1630.29%76.25K

--11.60K

3.85%10.65K

--4.11K

--4.41K

--10.26K

--0.00

Capital expenditures

-64.20%121.00K

136.67%71.00K

-35.56%58.00K

-75.00%13.00K

244.90%338.00K

328.57%30.00K

-75.74%90.00K

-60.90%52.00K

38.03%98.00K

-96.13%7.00K

461.64%371.00K

-44.92%133.00K

-66.78%71.00K

--180.86K

-74.46%66.06K

1179.12%241.46K

612.57%213.74K

-100.00%0.00

1642.52%258.68K

1221.92%18.88K

221.46%30.00K

1288.57%20.29K

364.49%14.85K

-87.54%1.43K

--9.33K

--1.46K

-62.32%3.20K

18.93%11.46K

-100.00%0.00

135.39%8.48K

183.92%9.64K

402.79%14.58K

-99.98%1.00

-95.28%3.60K

-70.74%3.40K

-72.78%2.90K

47.25%6.05K

1630.29%76.25K

--11.60K

3.85%10.65K

--4.11K

--4.41K

--10.26K

--0.00

Net cash flow from disposal of fixed assets

-64.20%121.00K

136.67%71.00K

-35.56%58.00K

-75.00%13.00K

244.90%338.00K

328.57%30.00K

-75.74%90.00K

-60.90%52.00K

38.03%98.00K

-96.13%7.00K

461.64%371.00K

-44.92%133.00K

-66.78%71.00K

--180.86K

-74.46%66.06K

1179.12%241.46K

612.57%213.74K

-100.00%0.00

1642.52%258.68K

1221.92%18.88K

221.46%30.00K

1288.57%20.29K

364.49%14.85K

-87.54%1.43K

--9.33K

--1.46K

-62.32%3.20K

18.93%11.46K

-100.00%0.00

135.39%8.48K

183.92%9.64K

402.79%14.58K

-99.98%1.00

-95.28%3.60K

-70.74%3.40K

-72.78%2.90K

47.25%6.05K

1630.29%76.25K

--11.60K

3.85%10.65K

--4.11K

--4.41K

--10.26K

--0.00

Net cash flow from business transactions

----

--0.00

100.00%0.00

----

--0.00

---53.00M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

64.20%-121.00K

-136.67%-71.00K

35.56%-58.00K

75.00%-13.00K

-244.90%-338.00K

-328.57%-30.00K

75.74%-90.00K

60.90%-52.00K

-38.03%-98.00K

96.13%-7.00K

-461.64%-371.00K

99.75%-133.00K

66.78%-71.00K

---180.86K

74.46%-66.06K

-281944.07%-53.24M

-612.57%-213.74K

100.00%0.00

-1642.52%-258.68K

-1221.92%-18.88K

-221.46%-30.00K

-1288.57%-20.29K

-364.49%-14.85K

87.54%-1.43K

---9.33K

---1.46K

62.32%-3.20K

-18.93%-11.46K

100.00%0.00

-135.39%-8.48K

-183.92%-9.64K

-402.79%-14.58K

99.98%-1.00

95.28%-3.60K

70.74%-3.40K

72.78%-2.90K

-47.25%-6.05K

-1630.29%-76.25K

---11.60K

-3.85%-10.65K

---4.11K

---4.41K

---10.26K

--0.00

Financing cash flow

Cash flow from continuous financing activities

-89.77%2.99M

15.03%16.39M

-30.05%21.27M

140.24%34.54M

2565.88%29.27M

712300.00%14.24M

-8.89%30.41M

-94.16%14.38M

-102.30%-1.19M

-100.19%-2.00K

-81.14%33.37M

226.09%246.08M

65.80%51.56M

54.36%1.07M

40236.54%176.95M

3728.01%75.46M

287.36%31.10M

-66.96%690.48K

-98.40%438.68K

-83.93%1.97M

1174.96%8.03M

-98.92%2.09M

5186.46%27.43M

-38.12%12.27M

-98.35%629.76K

2169.90%193.89M

-34.31%518.83K

1320.25%19.82M

5602.49%38.15M

-1.12%8.54M

507.85%789.84K

1765.54%1.40M

-104.61%-693.41K

-13.21%8.64M

785.20%129.94K

--74.81K

--15.04M

-78.21%9.95M

-89.00%14.68K

--0.00

-100.00%0.00

--45.67M

-93.11%133.46K

--241.72K

--1.94M

Net cash flow from debt Issuance/repayment

-67.58%-672.00K

-63.94%-541.00K

-113.50%-664.00K

-1247.31%-2.51M

-146.01%-401.00K

---330.00K

---311.00K

-100.62%-186.00K

-100.30%-163.00K

--0.00

-33.33%30.00M

--55.00M

--0.00

--45.00M

----

--0.00

-100.00%0.00

----

--0.00

--28.34M

----

-100.00%0.00

100.00%0.00

1631.33%12.76M

-200.00%-833.33K

---833.33K

-102.78%-277.78K

----

--10.00M

-100.00%0.00

--0.00

-100.00%0.00

--0.00

-94.88%100.00K

--255.00K

--1.95M

Net cash flow from common stock issuance/repurchase

-67.72%6.34M

-65.44%5.67M

-24.08%9.95M

189.71%32.63M

--19.65M

--16.42M

-61.18%13.10M

-94.99%11.26M

----

--0.00

-80.71%33.75M

630.65%225.00M

-100.00%0.00

--0.00

--174.98M

2708.44%30.79M

407.02%31.01M

-100.00%0.00

--0.00

-90.92%1.10M

--6.12M

-98.94%2.05M

--0.00

-37.99%12.07M

-100.00%0.00

2071.98%193.78M

-100.00%0.00

773.56%19.47M

17755.69%24.98M

0.29%8.92M

--1.59M

--2.23M

-99.05%139.92K

--8.90M

--0.00

--14.79M

-100.00%0.00

----

--45.55M

----

Proceeds from stock option exercised by employees

-41.41%9.98M

1236.06%15.34M

-23.49%15.52M

72.99%11.66M

581.13%17.04M

0.26%1.15M

370.00%20.29M

2.60%6.74M

546.25%2.50M

--1.15M

--4.32M

--6.57M

--387.00K

----

-100.01%-3.00

-100.00%3.00

----

-29.46%69.98K

7.66%34.99K

--144.87K

----

170.19%99.20K

-63.61%32.50K

-100.00%0.00

-870.12%-141.32K

508.45%89.31K

--18.74K

--201.16K

--18.35K

--14.68K

----

Proceeds from issuance of warrants

----

159.17%2.83M

598.51%3.06M

-81.60%176.41K

-90.51%181.64K

2666.29%1.09M

130.61%438.68K

403.60%958.89K

203.82%1.91M

-11.34%39.46K

-60.68%190.23K

-7.27%190.41K

53.54%629.76K

-88.30%44.51K

--483.84K

--205.34K

--410.16K

135.02%380.32K

----

--161.82K

--40.63K

--65.00K

--49.27K

----

Net cash flow from other financing activities

-80.47%-12.66M

-36.55%-4.09M

-32.26%-3.54M

-110.58%-7.25M

-98.98%-7.01M

-160.94%-2.99M

43.05%-2.67M

77.79%-3.44M

7.77%-3.52M

34.94%-1.15M

-327.19%-4.70M

-2960.74%-15.49M

-4214.06%-3.82M

-339.61%-1.76M

---1.10M

-502.41%-506.09K

---88.59K

---401.04K

100.00%0.00

---84.01K

----

--0.00

---1.10M

----

100.00%0.00

----

---26.00K

----

---8.93K

----

-153.55%-64.93K

-100.00%0.00

--0.00

100.00%0.00

--121.24K

309.16%33.47K

---13.28K

---16.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

-89.77%2.99M

15.03%16.39M

-30.05%21.27M

140.24%34.54M

2565.88%29.27M

712300.00%14.24M

-8.89%30.41M

-94.16%14.38M

-102.30%-1.19M

-100.19%-2.00K

-81.14%33.37M

226.09%246.08M

65.80%51.56M

54.36%1.07M

40236.54%176.95M

3728.01%75.46M

287.36%31.10M

-66.96%690.48K

-98.40%438.68K

-83.93%1.97M

1174.96%8.03M

-98.92%2.09M

5186.46%27.43M

-38.12%12.27M

-98.35%629.76K

2169.90%193.89M

-34.31%518.83K

1320.25%19.82M

5602.49%38.15M

-1.12%8.54M

507.85%789.84K

1765.54%1.40M

-104.61%-693.41K

-13.21%8.64M

785.20%129.94K

--74.81K

--15.04M

-78.21%9.95M

-89.00%14.68K

--0.00

-100.00%0.00

--45.67M

-93.11%133.46K

--241.72K

--1.94M

Net cash flow

Beginning cash balance

2.40%322.93M

-0.63%325.27M

-4.00%303.02M

-9.21%300.91M

-18.34%315.35M

-21.42%327.34M

-27.79%315.66M

34.45%331.44M

92.29%386.19M

83.09%416.56M

495.57%437.11M

191.02%246.51M

132.26%200.84M

98.49%227.52M

-48.03%73.39M

-48.56%84.71M

-52.97%86.47M

-43.36%114.62M

-25.94%141.22M

-16.55%164.66M

-16.41%183.88M

363.68%202.36M

254.74%190.68M

362.91%197.31M

1474.70%219.97M

186.73%43.64M

164.12%53.75M

60.05%42.62M

-58.94%13.97M

-51.94%15.22M

-46.44%20.35M

-40.84%26.63M

-7.09%34.02M

-6.53%31.67M

-1.95%37.99M

2.14%45.02M

-23.77%36.62M

633.36%33.89M

504.15%38.75M

--44.08M

1734.98%48.04M

--4.62M

821.69%6.41M

--2.62M

--695.93K

Current period cash flow changes

-23.43%-17.83M

80.49%-2.34M

90.48%22.26M

113.34%2.11M

73.62%-14.44M

60.53%-11.99M

156.86%11.68M

-108.28%-15.78M

-219.88%-54.75M

-13.84%-30.37M

-113.33%-20.55M

1784.75%190.60M

2687.60%45.67M

5.23%-26.68M

679.50%154.13M

51.74%-11.31M

90.81%-1.77M

-52.30%-28.15M

-327.74%-26.60M

-253.49%-23.44M

15.17%-19.22M

-110.48%-18.48M

215.50%11.68M

-159.59%-6.63M

-179.05%-22.65M

14183.16%176.32M

-97.07%-10.11M

277.17%11.13M

487.85%28.66M

-153.33%-1.25M

18.83%-5.13M

10.59%-6.28M

-187.95%-7.39M

-14.02%2.35M

-29.96%-6.32M

-31.90%-7.03M

312.24%8.40M

-93.71%2.73M

-171.21%-4.86M

---5.33M

-326.82%-3.96M

--43.42M

-363.98%-1.79M

---927.38K

--679.38K

Ending cash balance

1.39%305.11M

2.40%322.93M

-0.63%325.27M

-4.00%303.02M

-9.21%300.91M

-18.34%315.35M

-21.42%327.34M

-27.79%315.66M

34.45%331.44M

92.29%386.19M

83.09%416.56M

495.57%437.11M

191.02%246.51M

132.26%200.84M

98.49%227.52M

-48.03%73.39M

-48.56%84.71M

-52.97%86.47M

-43.36%114.62M

-25.94%141.22M

-16.55%164.66M

-16.41%183.88M

363.68%202.36M

254.74%190.68M

362.91%197.31M

1474.70%219.97M

186.73%43.64M

164.12%53.75M

60.05%42.62M

-58.94%13.97M

-51.94%15.22M

-46.44%20.35M

-40.84%26.63M

-7.09%34.02M

-6.53%31.67M

-1.95%37.99M

2.14%45.02M

-23.77%36.62M

633.36%33.89M

--38.75M

2507.50%44.08M

--48.04M

235.99%4.62M

--1.69M

--1.38M

Free cash flow

52.37%-20.82M

28.62%-18.72M

105.28%988.00K

-7.54%-32.44M

18.39%-43.71M

13.62%-26.23M

65.28%-18.72M

45.64%-30.16M

-809.11%-53.56M

-9.46%-30.37M

-136.24%-53.92M

-64.25%-55.48M

82.07%-5.89M

3.80%-27.74M

15.58%-22.82M

-32.92%-33.78M

-20.63%-32.87M

-40.18%-28.84M

-71.66%-27.03M

-34.48%-25.41M

-17.02%-27.25M

-17.11%-20.57M

-48.16%-15.75M

-117.37%-18.90M

-145.10%-23.28M

-79.38%-17.57M

-79.55%-10.63M

-13.24%-8.69M

-41.88%-9.50M

-55.68%-9.79M

8.22%-5.92M

-8.13%-7.68M

-0.84%-6.70M

12.90%-6.29M

-32.23%-6.45M

-33.30%-7.10M

-67.73%-6.64M

-220.30%-7.22M

-153.19%-4.88M

---5.33M

-238.57%-3.96M

---2.25M

-53.22%-1.93M

---1.17M

---1.26M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Axsome Therapeutics Inc Generate?



Axsome Therapeutics Inc generated -93.41M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Axsome Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Axsome Therapeutics Inc's operating cash flow increased by 27.26% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Axsome Therapeutics Inc Spend on Capital Expenditures?



Axsome Therapeutics Inc spent 480.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Axsome Therapeutics Inc's Financing Cash Flow Changed?



Axsome Therapeutics Inc used 101.47M in financing activities in the latest quarter.

What is free cash flow and why does it matter for AXSM?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Axsome Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -93.89M reflecting a 27.04% change from the previous year.